These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18371209)

  • 1. Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.
    Borggren M; Repits J; Kuylenstierna C; Sterjovski J; Churchill MJ; Purcell DF; Karlsson A; Albert J; Gorry PR; Jansson M
    Retrovirology; 2008 Mar; 5():28. PubMed ID: 18371209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression.
    Nabatov AA; van Montfort T; Geijtenbeek TB; Pollakis G; Paxton WA
    FEBS J; 2006 Nov; 273(21):4944-58. PubMed ID: 17010165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.
    Sterjovski J; Churchill MJ; Ellett A; Gray LR; Roche MJ; Dunfee RL; Purcell DF; Saksena N; Wang B; Sonza S; Wesselingh SL; Karlsson I; Fenyo EM; Gabuzda D; Cunningham AL; Gorry PR
    Retrovirology; 2007 Dec; 4():89. PubMed ID: 18076768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
    Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
    Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
    Hong PW; Nguyen S; Young S; Su SV; Lee B
    J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
    Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
    J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein V4 N- and C-terminals contribute to virus entry.
    Li Y; Yang D; Wang JY; Yao Y; Zhang WZ; Wang LJ; Cheng DC; Yang FK; Zhang FM; Zhuang M; Ling H
    PLoS One; 2014; 9(1):e86083. PubMed ID: 24465884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R5 human immunodeficiency virus type 1 with efficient DC-SIGN use is not selected for early after birth in vertically infected children.
    Borggren M; Navér L; Casper C; Ehrnst A; Jansson M
    J Gen Virol; 2013 Apr; 94(Pt 4):767-773. PubMed ID: 23223619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
    Edo-Matas D; Rachinger A; Setiawan LC; Boeser-Nunnink BD; van 't Wout AB; Lemey P; Schuitemaker H
    Virology; 2012 Jan; 422(1):70-80. PubMed ID: 22047989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
    Jansson M; Backström E; Scarlatti G; Björndal A; Matsuda S; Rossi P; Albert J; Wigzell H
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1405-14. PubMed ID: 11679153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.
    van Montfort T; Thomas AA; Pollakis G; Paxton WA
    J Virol; 2008 Aug; 82(16):7886-96. PubMed ID: 18524826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
    Repits J; Sterjovski J; Badia-Martinez D; Mild M; Gray L; Churchill MJ; Purcell DF; Karlsson A; Albert J; Fenyö EM; Achour A; Gorry PR; Jansson M
    Virology; 2008 Sep; 379(1):125-34. PubMed ID: 18672260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
    Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor.
    Lee B; Leslie G; Soilleux E; O'Doherty U; Baik S; Levroney E; Flummerfelt K; Swiggard W; Coleman N; Malim M; Doms RW
    J Virol; 2001 Dec; 75(24):12028-38. PubMed ID: 11711593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
    Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.